These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options.
    Author: Agnelli G, Caprini JA.
    Journal: J Surg Oncol; 2007 Sep 01; 96(3):265-72. PubMed ID: 17474075.
    Abstract:
    Cancer is a risk factor for venous thromboembolism (VTE). This risk is amplified by treatment with chemotherapy, radiation, or surgery. Thus, patients with cancer undergoing major surgery should receive appropriate prophylaxis. Available agents include low-dose unfractionated heparin (LDUH), low-molecular-weight heparin (LMWH), and Factor Xa inhibitors. Recent data suggest that Factor Xa inhibitors are safe and effective for VTE prevention in patients with cancer undergoing abdominal surgery. Further study in this patient population is warranted.
    [Abstract] [Full Text] [Related] [New Search]